O	0	3	The
O	4	17	effectiveness
O	18	20	of
B-intervention	21	32	mindfulness
I-intervention	32	33	-
I-intervention	33	38	based
I-intervention	39	45	stress
I-intervention	46	55	reduction
I-intervention	56	57	(
I-intervention	57	61	MBSR
I-intervention	61	62	)
O	63	66	for
O	67	76	survivors
O	77	79	of
O	80	86	breast
O	87	93	cancer
O	93	94	:
O	95	100	study
O	101	109	protocol
O	110	113	for
O	114	115	a
O	116	126	randomized
O	127	137	controlled
O	138	143	trial
O	143	144	.

O	145	150	After
O	151	160	treatment
O	161	171	completion
O	171	172	,
O	173	179	breast
O	180	186	cancer
O	187	188	(
O	188	190	BC
O	190	191	)
O	192	201	survivors
O	202	212	frequently
O	213	223	experience
O	224	232	residual
O	233	241	symptoms
O	242	244	of
O	245	249	pain
O	249	250	,
O	251	258	fatigue
O	258	259	,
O	260	264	high
O	265	271	levels
O	272	274	of
O	275	288	psychological
O	289	295	stress
O	295	296	,
O	297	304	anxiety
O	304	305	,
O	306	316	depression
O	316	317	,
O	318	322	fear
O	323	325	of
O	326	336	recurrence
O	336	337	,
O	338	341	and
O	342	352	metastasis
O	352	353	.

O	354	358	Post
O	358	359	-
O	359	368	treatment
O	369	375	stress
O	375	376	,
O	377	379	in
O	380	390	particular
O	390	391	,
O	392	395	can
O	396	405	adversely
O	406	412	affect
O	413	419	health
O	419	420	-
O	420	427	related
O	428	435	quality
O	436	438	of
O	439	443	life
O	443	444	,
O	445	450	which
O	450	451	,
O	452	454	in
O	455	459	turn
O	459	460	,
O	461	468	induces
O	469	474	onset
O	475	477	or
O	478	488	recurrence
O	489	491	of
O	492	499	chronic
O	500	508	diseases
O	508	509	.

O	510	519	Effective
O	520	533	interventions
O	534	538	that
O	539	545	target
O	546	551	these
O	552	565	psychological
O	566	574	symptoms
O	575	578	and
O	579	584	their
O	585	598	physiological
O	599	611	consequences
O	612	615	are
O	616	622	needed
O	622	623	,
O	624	634	especially
O	635	638	for
O	639	651	economically
O	652	665	disadvantaged
O	666	674	patients
O	674	675	.

O	676	683	However
O	683	684	,
O	685	687	in
B-location	688	693	China
O	693	694	,
O	695	698	few
O	699	707	evidence
O	707	708	-
O	708	713	based
O	714	726	intervention
O	727	737	strategies
O	738	742	have
O	743	747	been
O	748	759	established
O	760	765	among
O	766	768	BC
O	769	778	survivors
O	778	779	.

O	780	784	This
O	785	790	study
O	791	795	will
O	796	804	formally
O	805	810	adapt
O	810	811	,
O	812	819	develop
O	819	820	,
O	821	824	and
O	825	833	evaluate
O	834	836	an
O	837	846	intensive
O	847	858	mindfulness
O	858	859	-
O	859	864	based
O	865	871	stress
O	872	881	reduction
O	882	883	(
O	883	887	MBSR
O	887	888	)
O	889	901	intervention
O	902	910	protocol
O	911	913	to
O	914	921	improve
O	922	928	mental
O	929	935	health
O	935	936	,
O	937	944	quality
O	945	947	of
O	948	952	life
O	952	953	,
O	954	957	and
O	958	968	compliance
O	969	973	with
O	974	984	medication
O	985	990	among
B-ethinicity	991	998	Chinese
O	999	1001	BC
O	1002	1011	survivors
O	1011	1012	.

O	1013	1014	A
O	1015	1025	randomized
O	1025	1026	,
O	1027	1035	waitlist
O	1035	1036	-
O	1036	1046	controlled
O	1047	1055	clinical
O	1056	1061	trial
O	1062	1066	will
O	1067	1069	be
O	1070	1079	conducted
O	1079	1080	.

O	1081	1086	Based
O	1087	1089	on
O	1090	1093	our
O	1094	1099	power
O	1100	1111	calculation
O	1111	1112	,
B-total-participants	1113	1116	418
B-eligibility	1117	1119	BC
I-eligibility	1120	1129	survivors
I-eligibility	1130	1134	will
I-eligibility	1135	1137	be
I-eligibility	1138	1147	recruited
I-eligibility	1148	1152	from
I-eligibility	1153	1155	10
I-eligibility	1156	1159	low
I-eligibility	1159	1160	-
I-eligibility	1160	1166	income
I-eligibility	1167	1178	communities
O	1179	1181	in
B-location	1182	1190	Shanghai
O	1190	1191	.

O	1192	1195	All
O	1196	1204	subjects
O	1205	1209	will
O	1210	1212	be
O	1213	1221	randomly
O	1222	1230	assigned
O	1231	1237	either
O	1238	1240	to
O	1241	1244	the
O	1245	1249	MBSR
O	1250	1257	program
O	1258	1260	or
O	1261	1263	to
O	1264	1265	a
B-control	1266	1276	waitlisted
I-control	1277	1282	usual
I-control	1283	1287	care
O	1288	1295	regimen
O	1296	1300	that
O	1301	1305	will
O	1306	1311	offer
O	1312	1315	the
O	1316	1320	MBSR
O	1321	1328	program
O	1329	1334	after
O	1335	1338	the
O	1339	1349	completion
O	1350	1352	of
O	1353	1356	the
O	1357	1362	other
O	1363	1368	trial
O	1369	1372	arm
O	1373	1374	(
O	1374	1379	after
O	1380	1381	6
O	1382	1388	months
O	1389	1395	follow
O	1395	1396	-
O	1396	1398	up
O	1398	1399	)
O	1399	1400	.

O	1401	1404	Our
O	1405	1406	8
O	1406	1407	-
O	1407	1411	week
O	1412	1416	MBSR
O	1417	1429	intervention
O	1430	1437	program
O	1438	1442	will
O	1443	1450	provide
O	1451	1461	systematic
O	1462	1470	training
O	1471	1473	to
O	1474	1481	promote
O	1482	1488	stress
O	1489	1498	reduction
O	1499	1501	by
O	1502	1506	self
O	1506	1507	-
O	1507	1517	regulating
O	1518	1525	arousal
O	1526	1528	to
O	1529	1535	stress
O	1535	1536	.

O	1537	1548	Assessments
O	1549	1553	will
O	1554	1556	be
O	1557	1561	made
O	1562	1564	at
O	1565	1573	baseline
O	1573	1574	,
O	1575	1576	4
O	1577	1582	weeks
O	1583	1584	(
O	1584	1586	in
O	1587	1590	the
O	1591	1597	middle
O	1598	1600	of
O	1601	1604	the
O	1605	1610	first
O	1611	1615	MBSR
O	1616	1628	intervention
O	1628	1629	)
O	1629	1630	,
O	1631	1632	8
O	1633	1638	weeks
O	1639	1640	(
O	1640	1642	at
O	1643	1646	the
O	1647	1650	end
O	1651	1653	of
O	1654	1657	the
O	1658	1663	first
O	1664	1668	MBSR
O	1669	1681	intervention
O	1681	1682	)
O	1682	1683	,
O	1684	1685	6
O	1686	1692	months
O	1692	1693	,
O	1694	1697	and
O	1698	1700	12
O	1701	1707	months
O	1707	1708	,
O	1709	1712	and
O	1713	1717	will
O	1718	1725	include
O	1726	1734	measures
O	1735	1737	of
O	1738	1751	psychological
O	1752	1760	symptoms
O	1761	1762	(
O	1762	1772	depression
O	1772	1773	,
O	1774	1781	anxiety
O	1781	1782	,
O	1783	1786	and
O	1787	1796	perceived
O	1797	1803	stress
O	1803	1804	)
O	1804	1805	,
O	1806	1813	quality
O	1814	1816	of
O	1817	1821	life
O	1821	1822	,
O	1823	1826	and
O	1827	1837	medication
O	1838	1847	adherence
O	1847	1848	.

O	1849	1852	The
O	1853	1861	expected
O	1862	1869	outcome
O	1870	1874	will
O	1875	1877	be
O	1878	1881	the
O	1882	1893	improvement
O	1894	1896	in
O	1897	1910	psychological
O	1911	1919	symptoms
O	1919	1920	,
O	1921	1928	quality
O	1929	1931	of
O	1932	1936	life
O	1936	1937	,
O	1938	1941	and
O	1942	1952	medication
O	1953	1963	compliance
O	1964	1966	in
O	1967	1970	the
O	1971	1975	MBSR
O	1976	1988	intervention
O	1989	1994	group
O	1994	1995	.

O	1996	2000	This
O	2001	2006	study
O	2007	2011	will
O	2012	2016	help
O	2017	2024	develop
O	2025	2027	an
O	2028	2038	affordable
O	2038	2039	,
O	2040	2044	self
O	2044	2045	-
O	2045	2049	care
O	2050	2063	psychological
O	2064	2076	intervention
O	2077	2085	protocol
O	2086	2088	to
O	2089	2093	help
O	2094	2101	Chinese
O	2102	2104	BC
O	2105	2114	survivors
O	2115	2122	improve
O	2123	2128	their
O	2129	2136	quality
O	2137	2139	of
O	2140	2144	life
O	2144	2145	,
O	2146	2149	and
O	2150	2155	could
O	2156	2158	be
O	2159	2166	helpful
O	2167	2169	in
O	2170	2177	further
O	2178	2188	developing
O	2189	2199	affordable
O	2200	2207	disease
O	2208	2218	management
O	2219	2224	plans
O	2225	2228	for
O	2229	2237	patients
O	2238	2240	of
O	2241	2246	other
O	2247	2254	chronic
O	2255	2263	diseases
O	2263	2264	.

O	2265	2271	ChiCTR
O	2271	2272	-
O	2272	2275	IOR
O	2275	2276	-
O	2276	2284	14005390
O	2285	2286	(
O	2286	2288	10
O	2288	2289	/
O	2289	2291	27
O	2291	2292	/
O	2292	2296	2014
O	2296	2297	)
O	2297	2298	.
